The SLC25A4 gene helps move energy molecules in and out of mitochondria, the parts of cells that make usable energy. This gene plays an important role in tissues with high energy needs, especially skeletal muscle, heart, and the muscles that move the eyes. If it does not work well, cells may struggle to keep up with energy demands. Depending on the variant, this can lead to muscle weakness, drooping eyelids, limited eye movements, exercise intolerance, or heart muscle disease.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or guiding processes throughout the body. Some genes carry the directions for producing proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they take place, and how active they are. In combination, genes affect how the body grows and works, and they can influence your response to food, stress, and medicines. More detail is available in the LearnHub.
Overview
SLC25A4Gene function
What if the gene works
Inside mitochondria, the SLC25A4 gene helps swap ADP for ATP, the cell’s main energy molecule. This supports steady energy supply, especially in skeletal muscles and the heart.
Risk
What if the gene does not work
Variants in the SLC25A4 gene can disrupt energy supply in muscle cells, often causing mitochondrial disease with drooping eyelids and limited eye movement. Milder variants may appear later, while more severe variants can cause early weakness and cardiomyopathy.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the SLC25A4 gene, no SLC25A4-specific treatment or drug-selection approach is currently established. Care is guided by the person’s symptoms and organ involvement rather than by a medication choice linked to the SLC25A4 gene.
Conditions associated with SLC25A4
Gene function
What if the gene works
Every heartbeat, breath, and step depends on a quick flow of usable energy inside your cells. The SLC25A4 gene supports that flow by helping mitochondria, the parts of cells that supply energy, swap used energy molecules for freshly charged ones. This job is especially important in tissues that work almost nonstop, such as skeletal muscle and heart muscle.
Inside mitochondria, the SLC25A4 gene helps swap ADP (a lower-energy form) for ATP (the cell’s main energy carrier) across the inner membrane. This lets used energy molecules go in to be recharged while fresh ATP moves out for the cell to use.
This exchange connects the energy made in mitochondria with the jobs the rest of the cell needs to do. In simple terms, this is how the SLC25A4 gene helps mitochondria make energy available throughout the cell.
This gene is especially active in skeletal muscle and heart muscle, where cells need a constant energy supply. It helps these tissues keep up with repeated work such as movement and heartbeat.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many SLC25A4 gene variants change the protein’s shape, stability, or movement within mitochondria, so cellular energy transfer works less well and mitochondrial DNA may become depleted or build up multiple deletions. This helps explain how SLC25A4 gene variants affect mitochondrial function. Milder variants may leave some activity, while more severe variants can cause a larger loss of function and are often linked to earlier onset or more pronounced features.
How variants are linked to conditions
Pathogenic variants in the SLC25A4 gene cause rare inherited mitochondrial conditions. The best established SLC25A4 gene conditions are progressive external ophthalmoplegia, which often brings droopy eyelids and limited eye movement, and a more severe early-onset mitochondrial DNA depletion syndrome that can involve muscle weakness and cardiomyopathy. Some people with variants in the SLC25A4 gene also have a mitochondrial myopathy.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental influences are involved. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC25A4, risk is mainly linked to whether someone carries a disease-causing gene change, often inherited in a family. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce the chance of developing SLC25A4-related health problems.
Inheritance of SLC25A4 variants
The inheritance pattern for SLC25A4-related conditions can differ depending on the specific condition and variant. Some SLC25A4 variants are inherited in an autosomal dominant way, which means one changed copy can be enough to cause disease and each child of an affected parent has a 50% chance of inheriting it. Other SLC25A4-related conditions follow an autosomal recessive pattern, meaning a child must inherit two changed copies, one from each parent. In practical terms, the SLC25A4 inheritance pattern depends on whether the variant is linked to a dominant form of progressive external eye muscle weakness or a recessive mitochondrial condition.
What does my SLC25A4 result mean for my family?
Changes in the SLC25A4 gene can affect families in different ways, depending on the specific condition linked to the result. In some families, a changed copy can be passed from an affected parent, so close relatives may also carry it and may want to learn their own status. In other families, both parents may be healthy carriers, which can matter for siblings and future children. Because SLC25A4 is linked to more than one inherited pattern, the family meaning depends on the exact result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC25A4 variants usually uses a blood or saliva sample to read the SLC25A4 gene and look for changes in its DNA. It can identify a variant linked to an inherited condition and may also show whether other family members carry the same change.
When should I consider getting a genetic test?
Genetic testing for the SLC25A4 gene may be worth considering if you or a close relative has unexplained drooping eyelids, trouble moving the eyes, muscle weakness, exercise intolerance, or certain heart muscle problems. It can also help clarify some inherited conditions that affect how the body’s cells make energy.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they reveal depends on the condition and the specific type of variant. Over time, how the body works is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects. This kind of variation is common and is one reason medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. By looking at patterns between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC25A4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general questions about treatment, side effects, or possible interactions are best discussed with your doctor.
History
The SLC25A4 gene entered medical genetics through research on mitochondrial disease in the 1990s and early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, families with progressive eye muscle weakness helped researchers trace the cause to this gene, also known as ANT1. This was an important step because it linked changes in a nuclear gene to multiple deletions in mitochondrial DNA, which sharpened how doctors classified certain inherited muscle conditions. From these first observations, research expanded steadily, and the SLC25A4 gene became part of the broader story of how mitochondrial disorders can begin outside the mitochondrial genome itself. That shift helped shape modern testing for inherited progressive external ophthalmoplegia.